Baird Maintains Neutral on Molina Healthcare, Raises Price Target to $163

Benzinga Newsdesk www.benzinga.com Positive 53.6%

Neg 0% Neu 0% Pos 53.6%

Baird analyst Michael Ha maintains Molina Healthcare (NYSE:MOH) with a Neutral and raises the price target from $124 to $163.